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A B S T R A C T   
Optic atrophy-1 (OPA1) is a dynamin-like GTPase localized to the mitochondrial inner membrane, playing key 
roles in inner membrane fusion and cristae maintenance. OPA1 is regulated by the mitochondrial transmembrane 
potential (Δψm): when Δψm is intact, long OPA1 isoforms (L-OPA1) carry out inner membrane fusion. Upon loss 
of Δψm, L-OPA1 isoforms are proteolytically cleaved to short (S-OPA1) isoforms by the stress-inducible OMA1 
metalloprotease, causing collapse of the mitochondrial network and promoting apoptosis. Here, we show that L- 
OPA1 isoforms of H9c2 cardiomyoblasts are retained under loss of Δψm, despite the presence of OMA1. However, 
when H9c2s are differentiated to a more cardiac-like phenotype via treatment with retinoic acid (RA) in low 
serum media, loss of Δ ψm induces robust, and reversible, cleavage of L-OPA1 and subsequent OMA1 degra-
dation. These findings indicate that a potent developmental switch regulates Δ ψm-sensitive OPA1 cleavage, 
suggesting novel developmental and regulatory mechanisms for OPA1 homeostasis.   
1. Introduction 
Mammalian OPA1 is localized to the mitochondrial inner membrane, 
playing a key role in coordinating mitochondrial structure, bio-
energetics, and stress response. Expressed as 8 different mRNAs due to 
variable splicing (Delettre et al., 2001; Olichon et al., 2007; Akepati 
et al., 2008), mitochondrial OPA1 is present as five distinct protein 
isoforms. Two long (L-OPA1) isoforms can be cleaved at either the S1 or 
S2 sites to generate three short S-OPA1 isoforms (Griparic et al., 2007). 
L-OPA1 mediates inner membrane fusion (Song et al., 2007; Baricault 
et al., 2007), either by binding cardiolipin or through homodimeric 
association (Ban et al., 2017), while S-OPA1 isoforms are released into 
the intermembrane space and are fusion-inactive (Song et al., 2007; 
Ishihara et al., 2006). Loss of L-OPA1 and accumulation of S-OPA1 
promotes apoptosis (Head et al., 2009; Jiang et al., 2014) and autophagy 
(Chen et al., 2016). Consistent with this, increased expression of OPA1 
confers protection against apoptotic stimuli (Civiletto et al., 2015; 
Merkwirth et al., 2008), while loss of OPA1 expression sensitizes cells to 
apoptosis (Frezza et al., 2006); demonstrating the importance of OPA1 
to mitochondrial structure/function homeostasis and cellular stress 
response. 
L-OPA1 isoforms are cooperatively cleaved by the inner membrane 
proteases YME1L and OMA1 (Anand et al., 2014). YME1L constitutively 
cleaves L-OPA1 for steady-state levels of S-OPA1 (Griparic et al., 2007; 
Guillery et al., 2008), while OMA1 cleaves L-OPA1 in response to loss of 
transmembrane potential across the inner membrane (Δψm) (Head et al., 
2009; Ehses et al., 2009) as an inducible protease activated by a range of 
stress stimuli (Rainbolt et al., 2016). Following import to the mito-
chondria, OMA1 is cleaved to a mature form by AFG3L2 (Consolato 
et al., 2018). In response to loss of Δψm, OMA1 cleaves L-OPA1 and then 
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undergoes self-cleavage (Zhang et al., 2014) in a YME1L-dependent 
manner (Rainbolt et al., 2016). The activation of OMA1 in response to 
loss of Δψm requires the matrix-oriented N-terminal domain of OMA1 
(Baker et al., 2014); however, the underlying mechanism of stress- 
sensitive OMA1 activation remains unclear. 
Consistent with OPA1′s roles in mitochondrial homeostasis and 
apoptotic induction, recent work suggests that OPA1 has broad impor-
tance in cellular development and differentiation. Mitochondrial fusion 
is mechanistically involved in cell cycle progression (Mitra et al., 2009), 
with OPA1 specifically required for maintenance of germline stem cells 
(Sênos Demarco et al., 2019) and developmental angiogenesis (Herk-
enne et al., 2020). OPA1 expression is upregulated during cardiac dif-
ferentiation of stem cells (Magalhães-Novais et al., 2020), while 
disruption of OPA1 prevents cardiomyocyte differentiation (Kasahara 
et al., 2013), suggesting a key role for OPA1 in cardiac development. 
Despite the emerging importance of OPA1, however, developmental 
regulation of Δψm-sensitive OPA1 cleavage has not been reported. 
Previously, we found that OMA1 controls a sharply-defined threshold of 
Δψm required for OPA1-mediated mitochondrial fusion in 143B osteo-
sarcoma cells (Jones et al., 2017). In exploring whether a similar 
threshold might exist in H9c2 cardiomyoblasts, we find that L-OPA1 is 
retained despite loss of Δψm, but that Δψm-sensitive L-OPA1 cleavage is 
fully and reversibly activated by retinoic acid (RA)-mediated differen-
tiation. These findings indicate that a novel developmental switch 
potently activates Δψm-sensitive OPA1 cleavage, raising exciting new 
questions regarding the underlying mechanisms and developmental 
roles of OPA1-mediated mitochondrial stress response. 
2. Methods 
2.1. Cell culture 
H9c2 cardiomyoblasts from R. norvegicus (ATCC CRL-1446), 143B 
osteosarcomas, and OMA1+/+ and − /− mouse embryonic fibroblasts, 
were grown in Gibco Dulbecco’s Modified Eagle’s Medium (with high 
glucose, L-glutamine, phenol red, and sodium pyruvate) supplemented 
with 10% fetal bovine serum and Gibco antibiotic/antimycotic in 5% 
CO2 at 37 ◦C. For carbonyl cyanide chlorophenyl hydrazone (CCCP) 
treatments, CCCP (Sigma) was added to media from 1 mM stock in 
DMSO for indicated times and concentrations. Differentiation of H9c2s 
was performed using the method of Branco et al. (2015): 350,000 cells 
were plated per 10 cm dish in DMEM + 10% FBS. The following day, 
differentiation was initiated by replacing the media with DMEM + 1% 
FBS + 1 μM RA (Sigma, from 1 mM stock in DMSO). RA-mediated dif-
ferentiation proceeded for 5 days, with media changed every day. For 
undifferentiated controls, 50,000 cells were plated per 10 cm dish in 
DMEM + 10% FBS and grown alongside for 5 days. For galactose ex-
periments, cells were grown in DMEM lacking glucose (Gibco 
11966025) supplemented with sodium pyruvate and galactose with 
10% FBS for three passages prior to lysate preparation. 
2.2. Confocal imaging and analysis 
For immunofluorescence microscopy (Fig. 1), cultured cells grown 
on 22 × 22 mm glass coverslips in 6-well culture dishes were washed 
briefly with PBS and fixed with 4% paraformaldehyde (Electron Mi-
croscopy Sciences, Hatfield, PA) and permeabilized with 0.1% TX-100 in 
Fig. 1. Loss of Δψm causes fragmenta-
tion of the mitochondrial network. A. 
Confocal microscopy of H9c2 and 143B 
cells without or with CCCP treatment 
(10 μM, 1 h) immunolabeled for mito-
chondrial TOM 20 (green). Nuclei 
stained with DAPI (cyan). n = 3 experi-
ments (biological replicates). Size bar =
2 μm. B. ImageJ quantification of mito-
chondrial circularity calculated from 
confocal images (detail) in A. n = 25 
images for each, ± standard error. *** 
denotes p < 0.001. C. TMRE flow 
cytometry of H9c2 and 143B cells 
without or with CCCP, 10 μM, 1 h. n ≥ 3 
experiments, ± standard error. ** de-
notes p < 0.01.   
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PBS for 10 min. Samples were blocked with 10% normal goat serum and 
immunolabeled with anti-TOM20 rabbit polyclonal antibody (FL-145, 
Santa Cruz Biotechnology, Santa Cruz, CA) at 1:100 dilution in PBS 
(note: antibody FL-145 is no longer available; the replacement, FL-10, 
reacts with human but not rat). Coverslips were washed briefly with 
PBS and incubated with goat anti-mouse AlexaFluor488 (Invitrogen 
Molecular Probes, Carlsbad, CA), followed by staining with dia-
minophenylindole (DAPI) to visualize cell nuclei, washed with PBS, and 
mounted in 50% glycerol in PBS. For imaging of differentiated H9c2 cell 
morphology (Fig. 3A), cells were fixed in 4% paraformaldehyde, washed 
briefly, and incubated with AlexaFluor488 phalloidin (Invitrogen Mo-
lecular Probes) and DAPI, as above. Coverslips were visualized on an 
Olympus Fluoview FV10i confocal microscope (Olympus, Waltham, 
MA) using a 60x objective (UPLSA60x W, aperture 1.0, 3.0 optical 
zoom). To quantify mitochondrial circularity, blinded ImageJ analysis 
was used as previously (Dagda et al., 2009; Garcia et al., 2018): mi-
croscopy samples were prepared and imaged with generic labeling, 
generating a sample size of n = 25 high resolution images for analysis. 
For each high resolution image (examples: Fig. 1A, detail images), 
ImageJ calculated the average circularity of the mitochondrial profiles 
in that image using the ImageJ Mitochondrial Morphology macro (htt 
p://imagejdocu.tudor.lu/doku.php?id=plugin:morphology:mitocho 
ndrial_morphology_macro_plug-in:start). To monitor mitochondrial 
morphology (Fig. 3F), RA-treated H9c2s were labeled with 40 nM 
MitoTracker Red CMXRos (Invitrogen Molecular Probes, Eugene, Ore-
gon) for 20 min. followed by incubation in media lacking or containing 
10 μM CCCP for 1 h, fixation in 4% paraformaldehyde for 30 min., and 
mounting/visualization. 
2.3. Immunoblotting 
For SDS-PAGE Western blotting, cells on 10 cm dishes were lysed in 
Laemmli buffer with β-mercaptoethanol (Bio-Rad). Equal volumes of 
cell lysates were electrophoresed through 6% (for OPA1), 10% (for 
OMA1), or 10–20% (for all others) acrylamide gels and transferred to 
Immobilon PVDF (Bio-Rad). For cellular fractionation to obtain cyto-
solic and crude mitochondrial fractions, 4–6 10 cm dishes of actively- 
dividing H9c2s were pooled and processed using the Mitochondria 
Isolation Kit for Cultured Cells (ThermoFisher 89874), and mitochon-
drial pellets resuspended in 1% CHAPS in TBS. Protein concentration of 
cytosolic and mitochondrial fractions were measured by A280 using a 
NanoDrop spectrophotometer. 10 μg of protein were resuspended in 
Laemmli buffer with β -mercaptoethanol, electrophoresed on a 10% 
polyacrylamide gel and transferred to PVDF. Membranes were blocked 
with 5% nonfat milk in Tris-buffered saline + Tween (TBST). Primary 
antibody incubations were: OPA1 (BD Biosci. 612606) 1:500 overnight 
at 4 ◦C, OMA1 (Santa Cruz, H-11 sc-515788), 1:200 overnight at 4 ◦C, 
tubulin (Sigma, T6074) 1:1000 1 h, AFG3L2 (Invitrogen, PA5-48533) 
1:1000, Bax (Cell Signaling, 2272) 1:1000 overnight 4 ◦C, VDAC 
(Abcam ab14734) 1 mg/mL, YME1L (Abgent AP4882a) 1:1000. Mem-
branes were incubated with secondary goat anti-mouse poly-HRP 
(Invitrogen, 32230) or goat anti-rabbit poly-HRP at 1:3000 dilution for 1 
h, washed, and developed using WestDura SuperSignal (Thermo, 
34076). OMA1 blots required a high salt wash (1 g NaCl in 50 mL TBST) 
prior to developing. Blots were visualized using a GelDoc XR + Gel 
Documentation System (Bio-Rad). Each blot shown in a figure is repre-
sentative of results obtained in at least three independent biological 
replicates. Similarly, ImageJ quantitation of immunoblots was per-
formed on at least three independent biological replicates in all cases. 
2.4. Flow cytometry 
To monitor Δψm, TMRE flow cytometry was used as previously 
(Jones et al., 2017; Garcia et al., 2018). Cells in 10 cm dishes were 
incubated with 100 nM tetramethyl rhodamine ester (TMRE, Invitrogen) 
in fresh media for 20 min, washed twice with PBS, and resuspended in 1 
mL of PBS. Cells were analyzed on a BD FACSCelesta or LSR Fortessa (BD 
Biosciences). All flow cytometry graphs indicate the average peak 
fluorescence value and standard error of at least three independent 
biological replicates. 
2.5. DNA amplification and sequencing 
To examine the OMA1 nucleotide sequence encoding the N-terminal 
a.a. 122–141, forward primers TCAAGATGCCTCTCAAGTGC and 
CATTTCTGTAGGACTCTCAAGAA and reverse primer CTGCCCA-
CAATGATAGCAAG were used to amplify 241 and 211 nt, respectively, 
of Exon 1 of the OMA1 gene. Reactions included forward and reverse 
primer pairs, 1 μg of H9c2 total cellular DNA template, dNTPs, Taq 
polymerase (Roche), and DMSO in 80 μLs total volume. Amplifications 
were cycled at: 94 ◦C 1 min, 58 ◦C 1 min., 72 ◦C 5 min. for 39 cycles, 
followed by 72◦ 10 min. Reactions were checked via 1% agarose gel 
electrophoresis in 1X TAE buffer. Successful reactions were purified 
using Roche High Pure PCR Product Purification Kit. Three reactions of 
each forward/reverse primer pair amplification were sequenced by the 
University of Chicago DNA Sequencing and Genotyping Facility. 
Sequence data was compared with the NCBI reference sequence for 
R. norvegicus OMA1 (NM_001106669.1). 
2.6. Gene expression 
To analyze gene expression via quantitative reverse transcriptase 
PCR (qRT-PCR), H9c2 cells grown on 10 cm dishes were processed for 
total RNA using QIAGEN RNeasy kit, and cDNA prepared using Super-
script Reverse Transcriptase (Invitrogen, Carlsbad, CA). The following 
forward (F) and Reverse (R) primer sets to the indicated R. norvegicus 
mRNAs were used: ActB: F: TGTCACCAACTGGGACGATA R: 
CTTTTCACGGTTGGCCTTAG, AFG3L2: F: CTGCCTCCGTACGCTTTATC 
R: TTCAAATCCTTTGGGAGGTC, Atp2a2: F: TACTGACCCTGTCCCT-
GACC R: ACCATTTCATCCCGGATCTT, Bak: F: AAGTTGCCCAGGACA-
CAGAG R: TGTCCATCTCAGGGTTAGCA, Bax, F: 
TGCTAGCAAACTGGTGCTCA R: GGTCCCGAAGTAGGAAAGGA, Drp1: 
F: ATGGCAACATCAGAGGCACT R: ACTACCCTTCCCAATAAGG, Mybl2: 
F: CCACGAGGAGGATGAGCTAC R: CTGGATTCAAAACCCTCAGC, 
MyoD: F: CGTGGCAGTGAGCACTACAG R: TGTAGTAGGCGGCGTCG-
TAG, MyoG: F: TCCAGTACATTGAGCGCCTA R: GCTGTGGGAGTTG-
CATTCAC, Myom2: F: CACAGCGCTTTCATGTTTGT R: 
GGTGGTTTCCAAGTCACGAT, Oma1: F: ATCCTCTAAGCCCTGCTTCC R: 
GTAACATCCGTCCCCGTATT, Opa1: F: CATACTAGGATCGGCTGTTGG 
R: ACTGTAACACACCCTTTAACT p53: F: CAGTCAGGGACAGCCAAGTC 
R: GTACCAGGTGGAGGTGTGGA, Ryr1L: F: ATACTGTG-
GAGGCCGGTGTA R: GAGGTGGTGAGGCAACTCAG, Sln: F: 
CTGGAGTTCTCACCCAGACC R: TGGCCCCTCAGTATTGGTAG, Tnnt2: F: 
AGAGGACTCCAAACCCAAGC R: AGTCTGCAGCTCGTTCAGGT, YME1L: 
F: GCTTGTACAGGCAACATCCA R: TCTGTGCTTCTGCTAATCTTTCA. 
Samples were analyzed via SYBR Green on an Eco Illumina Real-time 
system (Illumina, San Diego, CA). Expression levels for each were 
normalized to actin (ActB). 
2.7. Statistical analyses 
Each experiment shown in the figures is representative of results 
obtained in at least three independent experiments (biological repli-
cates) for reproducibility. For ImageJ analyses of OPA1 isoforms, sam-
ples were analyzed via one-tailed Student’s t-test. Data presented are the 
averaged mean with standard error. For ImageJ analysis of mitochon-
drial circularity, images were analyzed using one-way ANOVA with 
Tukey’s HSD. Data presented are the average mean with standard error. 
For comparison of mRNA expression in H9c2s grown in standard versus 
differentiation media, samples were analyzed via Student’s t-test. In all 
experiments and analyses, P < 0.05 was considered to be statistically 
significant. *P < 0.05, **P < 0.01, and ***P < 0.001. 
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3. Results and discussion 
3.1. Loss of Δψm causes mitochondrial fragmentation in H9c2 
cardiomyoblasts 
CCCP is a protonophore that dissipates Δψm, causing mitochondrial 
fragmentation in cultured cells (Legros et al., 2002). Previously, we 
showed that a threshold of 34% Δψm, relative to untreated controls, is 
required for mitochondrial interconnection in 143B osteosarcoma cells 
(Jones et al., 2017). To explore Δψm-sensitive mitochondrial dynamics 
in cardiac-derived cells, H9c2 cardiomyoblasts and control 143B cells 
were incubated with 10 μM CCCP for 1 h, followed by immunofluores-
cence to visualize mitochondrial organization. Untreated H9c2s dis-
played mitochondrial organization of both interconnected reticular and 
isolated organelles, reflecting a balance of fission and fusion events. In 
response to challenge with CCCP, the mitochondrial network of H9c2s 
was disrupted to a completely fragmented state (Fig. 1A). Similarly, 
upon CCCP challenge, mitochondria of 143B cells collapsed to a frag-
mented collection of round organelles (Fig. 1A), consistent with previ-
ous results (Jones et al., 2017). Blinded ImageJ quantification of 
mitochondrial images (Dagda et al., 2009; Garcia et al., 2018) revealed 
significant increases in mitochondrial circularity for untreated versus 
CCCP-treated H9c2s (0.46 ± 0.02 versus 0.66 ± 0.01) and for control 
143Bs (0.45 ± 0.02 versus 0.65 ± 0.02) (Fig. 1B), demonstrating 
mitochondrial fragmentation in both cell lines in response to CCCP. Flow 
cytometry using tetramethyl rhodamine ester (TMRE) allows moni-
toring of Δψm (Jones et al., 2017; Gilkerson et al., 2012): TMRE fluo-
rescence was significantly decreased in untreated versus CCCP-treated 
cells of both H9c2s (10177 ± 715 versus 4858 ± 268 a.u.) and 143Bs 
(4858 ± 268 a.u. versus 385 ± 23 a.u.) (Fig. 1C), demonstrating dissi-
pation of Δψm in both H9c2 cardiomyoblast and 143B osteosarcoma cell 
lines. These data demonstrate that loss of Δψm via CCCP treatment 
Fig. 2. Δψm-sensitive cleavage of OPA1 is not activated in H9c2 cells. A. H9c2 and 143B cells were challenged with CCCP (10 μM, 1 h) followed by OPA1 
immunoblotting. n = 4 experiments (biological replicates). B. ImageJ quantification of L-OPA1 in H9c2s and 143Bs. n = 3 experiments, ± standard error. *** denotes 
p < 0.001. C. OPA1 immunoblotting of H9c2 and 143B cell lysates following challenge with CCCP (10 μM, 4 h), n = 3 experiments. D. OMA1 immunoblotting of 
143B, H9c2 and OMA1+/+ and − /− cell lysates treated with 10 μM CCCP for 0, 1, or 4 h, n = 4 experiments. E. YME1L immunoblotting of 143B and H9c2 cell 
lysates treated with 10 μM CCCP for 0, 1, or 4 h, n = 3 experiments. F. AFG3L2 immunoblotting of 143B and H9c2 cell lysates treated with 10 μM CCCP for 0, 1, or 4 
h, n = 3 experiments. G. Representative electropherogram of DNA sequence analysis of OMA1 nt445-473, encoding the N-terminal Δ ψm sensor domain. Identical 
results were obtained in sequencing reactions of two independent primer sets, with three amplicons of each sequenced. H. Alignment of reference sequence (ref) NCBI 
NM_001106669 and H9c2 sequence at nt445-473, indicating no sequence differences (blue). 
I. Garcia et al.                                                                                                                                                                                                                                   
Mitochondrion 57 (2021) 88–96
92
causes loss of mitochondrial interconnection in H9c2 cardiomyoblast 
cells, consistent with results in other cellular backgrounds (Legros et al., 
2002). We next examined the status of mitochondrial OPA1 in this 
setting. 
3.2. L-OPA1 is retained in H9c2s following loss of Δψm, despite the 
presence of OMA1 
OPA1 is cleaved by the YME1L and OMA1 proteases, creating a 
steady-state equilibrium of long, fusion-active L-OPA1 and short, fusion- 
inactive S-OPA1 isoforms (Anand et al., 2014). In response to loss of 
Δψm, however, L-OPA1 is typically cleaved to S-OPA1 isoforms (Gri-
paric et al., 2007; Baricault et al., 2007). OPA1 immunoblotting showed 
that untreated H9c2s maintain steady-state L-OPA1 and S-OPA1 levels. 
Strikingly, however, under CCCP challenge (10 μM, 1 h), untreated and 
CCCP-treated H9c2s maintained equivalent proportions of L-OPA1 
(Fig. 2A). Conversely, untreated 143B cells maintained a balance of L- 
OPA1 and S-OPA1, while CCCP induced the expected loss of L-OPA1 and 
concomitant accumulation of S-OPA1 (Fig. 2A), as shown previously 
(Jones et al., 2017). ImageJ quantification confirmed that in H9c2s there 
was no difference in L-OPA1 levels in untreated (59.2 ± 4%) versus 
CCCP-treated cells (58.9 ± 2%) (Fig. 2B), while untreated 143B cells had 
significantly greater L-OPA1 than CCCP-treated cells (52.5 ± 4% versus 
16.5 ± 0.6%). The CCCP-induced mitochondrial fragmentation in Fig. 1 
is surprising in light of the presence of L-OPA1 in H9c2s under CCCP 
challenge. Notably, OPA1-mediated mitochondrial fusion is opposed by 
mitochondrial fission, mediated by recruitment of dynamin-related 
protein-1 (DRP1) to the organelle, where it carries out membrane scis-
sion. Mitochondrial recruitment of DRP1 is carried out by the actin 
cytoskeleton (Ji et al., 2015; Hatch et al., 2014; Moore, 2016) in 
response to stimuli including AMP kinase (Toyama et al., 2016) and 
uncouplers (Cereghetti et al., 2008), suggesting that the observed CCCP- 
induced mitochondrial fragmentation is mediated by DRP1. Moreover, 
longer incubation with CCCP (four hours) also failed to elicit any 
appreciable L-OPA1 cleavage (Fig. 2C). These data demonstrate that L- 
OPA1 is retained under loss of Δ ψm in H9c2s, representing a novel 
departure from Δ ψm-sensitive OPA1 dynamics reported in other cell 
settings (Griparic et al., 2007; Ishihara et al., 2006; Ehses et al., 2009; 
Rainbolt et al., 2016). 
As Δψm-sensitive cleavage of L-OPA1 is carried out by OMA1 (Head 
et al., 2009; Ehses et al., 2009), we next tested whether OMA1 was 
present in H9c2s. OMA1 immunoblotting of lysates from untreated 143B 
and H9c2 cells both displayed signal for OMA1, which was missing from 
control OMA1− /− cells (Fig. 2D), demonstrating that the lack of OPA1 
cleavage in CCCP-treated H9c2s was not due to the absence of OMA1. In 
response to loss of Δψm, OMA1 activates proteolysis of L-OPA1, followed 
by degradation of OMA1 (Rainbolt et al., 2016; Zhang et al., 2014). 
While OMA1 was present in untreated 143B cells, 143Bs showed loss of 
OMA1 signal after 4 h of CCCP treatment, relative to loading controls. 
Conversely, H9c2s showed no reduction in OMA1 in response to CCCP 
challenge at 1 or 4 h. (Fig. 2D), indicating that OMA1 activation and 
degradation did not occur. OMA1 degradation following loss of Δψm 
requires YME1L (Rainbolt et al., 2016), but YME1L is present in both 
H9c2s and 143Bs without and with CCCP challenge (Fig. 2E). Similarly, 
the matrix-localized AFG3L2 protease cooperates with YME1L to regu-
late OMA1 activity (Consolato et al., 2018). AFG3L2 immunoblotting 
revealed that both H9c2 and 143B cells displayed AFG3L2 signal, 
though H9c2s displayed less, relative to loading controls (Fig. 2F). Thus, 
OMA1, and its partners YME1L and AFG3L2, are expressed in H9c2s, but 
OMA1 is apparently neither activated nor degraded in response to loss of 
Δψm. 
Langer and co-workers found that a conserved N-terminal domain of 
OMA1 (a.a. 144–163) is required for its activation and cleavage of L- 
OPA1 following dissipation of Δψm (Baker et al., 2014). To test whether 
the lack of L-OPA1 cleavage under CCCP challenge in H9c2s (Fig. 2A) 
might be due to a mutation in the corresponding domain of the rat 
OMA1 gene, we examined the relevant sequence via PCR of isolated 
H9c2 DNA. The a.a.144–163 domain of human OMA1 corresponds to 
the rat OMA1 a.a. 122–141, encoded by nt445-473 of the OMA1 coding 
sequence. PCR amplification and sequencing of this region (Fig. 2G) 
demonstrated that this region in H9c2s is identical to the NCBI reference 
sequence (Fig. 2H), indicating that the observed insensitivity of OMA1 
to loss of Δψm in H9c2s is not due to mutation or deletion of OMA1′s 
Δψm sensor domain (Baker et al., 2014). 
Taken together, these results indicate that L-OPA1 isoforms are 
retained in H9c2 cardiomyoblasts despite loss of Δψm, likely through a 
failure to activate OMA1. In vivo, OPA1 plays a key role as an apoptotic 
switch in cardiac tissue (Wai, 2015). We therefore investigated whether 
cardiac-like differentiation of H9c2s would potentiate Δ ψm-sensitive 
OPA1 cleavage in this system. 
3.3. Retinoic acid-mediated differentiation activates L-OPA1 cleavage in 
H9c2s 
H9c2 cells can be induced to differentiate towards skeletal or cardiac 
muscle phenotypes: when grown in low-serum media, H9c2 cells form 
myotubes and express skeletal muscle markers, while growth in low- 
serum media containing RA promotes expression of cardiac markers 
for a cardiomyocyte-like phenotype (Branco et al., 2015, 2011). To 
explore the impact of cardiac differentiation on Δψm-sensitive L-OPA1 
cleavage, H9c2s were grown in differentiation media containing 1% FBS 
with 1 μM RA for 5 days (Branco et al., 2015). When visualized by 
confocal microscopy, H9c2s grown in standard media (DMEM contain-
ing 10% FBS) showed blast-type morphology consistent with actively- 
dividing cultured cells. When grown in media containing 1% FBS +
RA, however, H9c2s transitioned to an elongate cellular morphology, 
with frequent binucleate cells (Fig. 3A), consistent with differentiation 
to a more cardiac-like state (Branco et al., 2015). To examine cardiac- 
specific differentiation, mRNAs were examined by quantitative reverse 
transcription PCR (qRT-PCR). Strikingly, significant increases in the 
expression of cardiac-specific genes were observed in differentiated 
H9c2s: cardiac troponin T (Tnnt2, 24-fold), myomesin 2 (Myom2, 7- 
fold), myogenin (Myog, 3.5-fold), ryanodine receptor 1 (Ryr1l, 4-fold), 
sarcolipin (Sln, 7-fold), and the sarcoplasmic calcium transporter 
ATP2a1 (5-fold) all showed significantly increased mRNA expression. 
Conversely, the Mybl2 cell cycle progression factor showed decreased 
expression, while expression of Myod, which promotes skeletal (not 
cardiac) muscle differentiation, was not increased (Fig. 3B). Taken 
together, these data indicate that H9c2s differentiate upon treatment 
with low serum plus RA, exiting the cell cycle and committing to a 
cardiac-specific state. We next examined the effect of RA-mediated dif-
ferentiation on Δψm-sensitive OPA1 cleavage in H9c2s. 
Following incubation in differentiation media, control and differ-
entiated H9c2s were challenged with CCCP. Undifferentiated H9c2s 
maintained an average TMRE value of 5881 ± 568 a.u., falling to 1367 
± 542 in response to CCCP for a significant decrease in Δψm. Differen-
tiated H9c2s had a TMRE value of 6865 ± 292, decreasing to 1998 ± 378 
following CCCP treatment (Fig. 3C). Thus, the loss of TMRE in response 
to CCCP was equivalent in undifferentiated versus RA-differentiated 
H9c2s. OPA1 immunoblotting revealed that untreated H9c2s had a 
balance of both L-OPA1 and S-OPA1 isoforms, maintaining L-OPA1 
under CCCP challenge, as in Fig. 2. RA-treated H9c2s similarly main-
tained both L-OPA1 and S-OPA1 isoforms. Strikingly, however, RA- 
treated H9c2s showed a dramatic loss of L-OPA1 in response to CCCP 
treatment (Fig. 3D). ImageJ quantification confirmed that while undif-
ferentiated H9c2s showed no difference in L-OPA1 levels (61 ± 4% 
control versus 56 ± 4% CCCP-treated), RA-differentiated H9c2s showed 
a robust, significant loss of L-OPA1 in response to CCCP challenge (57 ±
3% control versus 16 ± 5% CCCP-treated) (Fig. 3E). Consistent with this, 
RA-treated H9c2s maintain interconnected mitochondria, collapsing to 
a fragmented morphology upon CCCP treatment (Fig. 3F). These results 
demonstrate that Δψm-sensitive L-OPA1 cleavage is vigorously activated 
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in RA-differentiated H9c2 cells. As loss of Δψm activates OMA1 cleavage 
of L-OPA1, followed by subsequent YME1L-dependent degradation of 
OMA1 (Rainbolt et al., 2016; Zhang et al., 2014), we next examined 
whether RA differentiation restored degradation of OMA1 following 
CCCP challenge. In undifferentiated H9c2s, OMA1 was not degraded 
following CCCP challenge of 1 or 4 h. In RA-differentiated H9c2s, 
however, CCCP induced loss of OMA1 after 4 h. (Fig. 3G), consistent 
with CCCP-induced activation and subsequent degradation of OMA1 in 
RA-differentiated H9c2s. Together, these results demonstrate that RA- 
mediated differentiation robustly activates CCCP-induced L-OPA1 
cleavage, and indicate that Δψm-sensitive OPA1 cleavage is regulated by 
a developmental switch in H9c2 cells. 
3.4. RA-mediated OPA1 cleavage is reversible and chloramphenicol- 
insensitive 
To explore potential mechanisms of this intriguing switch, we 
examined the mRNA expression of factors involved in mitochondrial 
dynamics and candidate interacting factors. While RA differentiation 
did not alter the expression of OPA1, OMA1, DRP1, YME1L, or p53, RA 
differentiation caused significant increases in the expression of AFG3L2 
(2-fold) and pro-apoptotic factors Bax (1.8-fold) and Bak (1.5-fold) 
(Fig. 4A). As an inhibitor of mitochondrial protein synthesis (Storrie and 
Attardi, 1973; Hilander et al., 2018), chloramphenicol (CAP) prevents 
stress-induced OPA1 cleavage in cells with decreased AFG3L2 (Mancini 
et al., 2019; Richter et al., 2019). To examine whether RA-induced OPA1 
cleavage is sensitive to CAP, H9c2s were differentiated for five days, as 
above, in the absence or presence of CAP for the final three days 
(Hilander et al., 2018), followed by CCCP treatment. RA-differentiated 
H9c2s maintain L-OPA1, which is strongly cleaved following CCCP 
challenge, as above. RA-differentiated H9c2s treated with CAP prior to 
challenge with CCCP also show complete cleavage of L-OPA1 (Fig. 4B), 
demonstrating that RA-induced OPA1 cleavage is not CAP-sensitive and 
indicating that the observed switch is not dependent on mitochondrial 
Fig. 3. RA-mediated differentiation acti-
vates Δψm-sensitive OPA1 cleavage in 
H9c2s. A. Confocal imaging of H9c2s grown 
in standard (DMEM + 10% FBS) or differ-
entiation media (DMEM + 1% FBS + 1 μM 
RA) for five days. Actin (phalloidin, green), 
and nuclei (DAPI, blue) were visualized by 
confocal microscopy. B. Gene expression of 
differentiation markers in H9c2s in standard 
(white) or differentiation (black) media. 
qRT-PCR for indicated mRNAs, ± standard 
error. ** denotes p < 0.01. C. TMRE flow 
cytometry analysis for Δ ψm in standard or 
differentiation media without or with 10 μM 
CCCP, 1 h. n = 3 experiments. D. H9c2s 
grown in standard or differentiation media 
were challenged with CCCP for 1 h followed 
by immunoblotting for OPA1. E. ImageJ 
quantification of OPA1 immunoblots. n = 4 
experiments, ± standard error. *** denotes p 
< 0.01. F. Mitochondrial morphology of 
H9c2s differentiated with 1% FBS + 1 μM 
RA. Cells were incubated with MitoTracker, 
followed by CCCP challenge and fixation. 
Mitochondria (MitoTracker, red) and nuclei 
(DAPI, blue) were visualized by confocal 
microscopy. n = 3 expts. G. OMA1 and 
tubulin immunoblotting of H9c2s grown in 
standard or differentiation media challenged 
with 10 μM CCCP for 0, 1, or 4 h, n = 4 ex-
periments. (For interpretation of the refer-
ences to colour in this figure legend, the 
reader is referred to the web version of this 
article.)   
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protein synthesis. 
Given the increased expression of pro-apoptotic Bax and Bak in RA- 
treated H9c2s, we next examined whether Bax is involved in RA-induced 
OPA1 cleavage. Bax is a cytosolic factor that is translocated to mito-
chondria in response to a variety of stimuli, where it promotes cyto-
chrome c release and subsequent caspase-mediated apoptosis (Eskes 
et al., 2000; Wolter et al., 1997). Bax and Bak oligomerize within the 
mitochondria to activate OMA1 (Jiang et al., 2014). To test whether 
increased mitochondrial translocation of Bax correlates with RA- 
induced OPA1 cleavage, cytosolic and mitochondrial fractions of con-
trol and RA-differentiated H9c2s (without or with CCCP) were prepared. 
In undifferentiated H9c2s, Bax was predominantly found in the cytosolic 
fraction, coincident with tubulin. Faint Bax bands were found in 
mitochondrial fractions, coincident with mitochondrial voltage- 
dependent anion channel (VDAC) (Fig. 4C). Similarly, RA- 
differentiated H9c2s showed strong Bax signal in the cytosolic frac-
tions of control and CCCP-treated cells, with faint bands in the mito-
chondrial fractions (Fig. 4C). As such, RA differentiation does not appear 
to cause an appreciable increase in mitochondrial translocation of Bax in 
response to CCCP. 
OPA1 processing is modulated in RPE1 cells by changing from high 
glucose media to glucose-free media supplemented with galactose 
(MacVicar and Lane, 2014), thus switching from glycolytic to oxidative 
metabolism (Rossignol et al., 2004). To test whether OPA1 processing in 
H9c2s is impacted by metabolic shifting, H9c2s were incubated in 
DMEM lacking glucose supplemented with galactose, followed by CCCP 
Fig. 4. RA-mediated activation of Δψm-sensitive OPA1 cleavage is reversible, but chloramphenicol-insensitive. A. qRT-PCR of indicated mRNAs from H9c2s grown in 
standard (10% FBS, white) or differentiation (1% FBS + RA, black) media, ± standard error. ** denotes p < 0.01. B. OPA1 immunoblotting of RA-differentiated 
H9c2s treated with CAP (40 μg/mL, 3 d) and challenged with CCCP (10 μM, 1 h). n = 3 experiments. C. Immunoblotting of cytosolic (c) and mitochondrial (m) 
fractions (10 μg per lane) from H9c2s in regular (10% FBS) and differentiation (1% FBS + RA) media, without or with CCCP. n = 3 experiments. D. OPA1 and tubulin 
immunoblotting of H9c2s grown in glucose (+glu) or galactose (-glu + gal) media and challenged with CCCP (10 μM, 1 h). n = 3 experiments. E. OPA1 and tubulin 
immunoblotting of cell lysates from 10% FBS, 1% FBS + RA, and RA + recov. H9c2s were differentiated in 1% FBS + RA for 5 d and then allowed to recover for 5 d in 
10% FBS (RA + recov.). n = 3 experiments. F. ImageJ quantification of OPA1 immunoblots in E. n = 3 experiments, ± standard error. * denotes p < 0.05, **denotes 
p < 0.01, ***denotes p < 0.001. 
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challenge. H9c2s grown in high glucose maintain L-OPA1 isoforms, 
either without or with CCCP challenge (Fig. 4D), as in Fig. 2. Similarly, 
H9c2s grown in media lacking glucose, supplemented with galactose, 
retain L-OPA1, even under CCCP challenge (Fig. 4D), indicating that 
shifting metabolism does not activate OPA1 processing in H9c2s. 
Consistent with this, RA-mediated differentiation of H9c2s does not 
significantly alter steady-state Δ ψm of H9c2s (Fig. 3C). Moreover, RA- 
mediated differentiation is carried out in high glucose media. Taken 
together, these results suggest that the observed induction of Δ ψm- 
sensitive OPA1 processing in RA-treated H9c2s is not mediated by 
increased mitochondrial metabolism. We next tested whether RA in-
duction of Δ ψm-sensitive L-OPA1 cleavage is reversible. H9c2s were 
differentiated for 5 days in RA, followed by recovery in media with 10% 
FBS lacking RA for an additional 5 days. While untreated H9c2s showed 
no L-OPA1 cleavage in response to CCCP, RA-differentiated H9c2s dis-
played robust cleavage of L-OPA1 in response to CCCP challenge (as in 
Fig. 3D). Differentiated H9c2s allowed to recover in DMEM with 10% 
FBS, however, retain L-OPA1 when challenged with CCCP (Fig. 4E). 
ImageJ quantification confirms that while H9c2s that recover in stan-
dard media do show some reduction in L-OPA1 under CCCP challenge, 
they retain significantly more L-OPA1 than RA-differentiated H9c2s 
given CCCP (Fig. 4F). These results demonstrate that the induction of 
Δψm-sensitive L-OPA1 cleavage in differentiated H9c2s is reversible 
upon removal of RA and restoration of serum. 
The robust switching of Δψm-sensitive L-OPA1 cleavage suggests that 
RA differentiation activates a potent regulatory mechanism for OMA1, 
opening new avenues of inquiry regarding the mechanistic regulation of 
Δψm-sensitive OPA1 cleavage, as well as a novel developmental role for 
this stress-sensing mechanism. Mechanistically, the stress-sensitive 
activation of OMA1 remains unclear. Our findings add a provocative 
new element to this question, suggesting that an unknown, 
developmentally-regulated molecular ‘clutch’ is able to engage, and 
disengage, this key mechanism of mitochondrial stress response. OMA1 
interacts with YME1L (Song et al., 2007; Anand et al., 2014; Rainbolt 
et al., 2016), AFG3L2 (Consolato et al., 2018), and cardiolipin (allowing 
indirect association with prohibitin (Anderson et al., 2020), suggesting 
that improved understanding of OMA1′s homo-oligomeric structure 
(Bohovych et al., 2014), interacting partners, and the inner membrane 
proteolipid environment will be crucial to fully delineating the mecha-
nisms behind stress-sensitive cleavage of OPA1. Developmental regula-
tion of L-OPA1 cleavage has not been demonstrated previously, despite 
emerging evidence indicating potent roles for OPA1 in differentiation: 
ablation of OPA1 disrupts neural (Caglayan et al., 2020) and cardiac 
development (Kasahara et al., 2013), as well as stem cell maintenance 
(Sênos Demarco et al., 2019). A developmental switch activating stress- 
sensitive OPA1 cleavage in differentiated cardiac cells is consistent with 
OPA1′s established role in priming cells for apoptosis (Head et al., 2009; 
Jiang et al., 2014) and induction of pro-apoptotic factors in RA- 
differentiated H9c2s (Fig. 4A; y (Branco et al., 2015). These findings 
hold exciting potential for other cell settings, including stem, neuronal, 
and additional cardiac cell systems, in exploring the generality of this 
intriguing switch. 
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